Related Experiment Video

Updated: Oct 17, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

A single d(GpG) cisplatin adduct on the estrogen response element decreases the binding of the estrogen receptor

L Massaad-Massade1, C Massaad, F Legendre

  • 1Université René Descartes, Laboratoire de Toxicologie Moléculaire, U-490 INSERM, 45 rue des Saints-Pères, 75270, Paris, France. liliane.massade@biomedicale.univ-paris5.fr

FEBS Letters
|January 29, 2000
PubMed

Insights

Cisplatin's DNA adducts, specifically d(GpG)cisPt, reduce estrogen receptor (ER) binding to estrogen response elements (ERE). DNA bending by these adducts is not critical for initial ER-ERE recognition, impacting ER-DNA interactions.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Genetics

Background:

  • Estrogen receptor (ER) binding to estrogen response elements (ERE) is crucial for gene regulation.
  • Cisplatin is a chemotherapy drug that forms DNA adducts, including d(GpG)cisPt.
  • Both ER and cisplatin are known to induce DNA bending.

Purpose of the Study:

  • To investigate how the d(GpG)cisPt adduct influences ER binding to ERE-like sequences.
  • To determine the role of DNA bending induced by cisplatin adducts in ER recognition of ERE.

Main Methods:

  • Design of three ERE-like oligonucleotides with varying ER affinities and a central GG sequence.
  • Formation of a single central d(GpG)cisPt adduct within the linker region of oligonucleotides.
  • Electrophoretic mobility shift assay (EMSA) and Scatchard analysis to assess ER-DNA binding.

Main Results:

  • A single d(GpG)cisPt adduct in the linker sequence significantly decreased ER affinity for DNA.
  • Platination of DNA outside the ERE half-sites also reduced ER interaction with ERE.
  • These findings suggest DNA bending by the adduct is not essential for initial ER-ERE recognition.

Conclusions:

  • The presence of cisplatin-induced d(GpG)cisPt adducts impairs estrogen receptor binding to DNA.
  • DNA bending induced by these adducts does not play a critical role in the initial recognition of ERE by ER.
  • Cisplatin's interaction with DNA, even outside EREs, can disrupt ER-DNA complex formation.

More Related Videos

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay09:07

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay

Published on: December 19, 2018

Related Concept Videos

GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
G Protein-coupled Receptors01:27

G Protein-coupled Receptors

G-protein-coupled receptors are ligand-binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that traverses the cell membrane seven times, creating intracellular and extracellular loops. The extracellular loops create a ligand-specific pocket which binds to neurotransmitters or hormones. The intracellular loops hold onto the G-protein.The G-protein, or guanine nucleotide-binding protein, is a large heterotrimeric complex. Its three subunits...